Hjem › Akut lungeskade
Akut lungeskade kliniske forsøg rekrutterer i USA
13 studier for Akut lungeskade rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Cleveland, OH5 studier
- New York City, NY5 studier
- Mountain View, CA5 studier
- Nashville, TN5 studier
- Durham, NC5 studier
- Seattle, WA5 studier
- Washington, DC5 studier
- Rochester, MN4 studier
- Sacramento, CA4 studier
- Edison, NJ4 studier
- Houston, TX4 studier
- The Bronx, NY4 studier
- Birmingham, AL4 studier
- Oklahoma City, OK4 studier
- Detroit, MI4 studier
- Orange, CA4 studier
- Somerville, MA4 studier
- Fort Worth, TX4 studier
- Long Beach, CA4 studier
- Peoria, IL4 studier
- Toledo, OH4 studier
- Boston, MA4 studier
- Boise, ID4 studier
- Sarasota, FL4 studier
- Ann Arbor, MI4 studier
- Gainesville, FL4 studier
- Charleston, SC4 studier
- Evanston, IL4 studier
- Charlottesville, VA4 studier
- St. Petersburg, FL4 studier
- Portland, OR4 studier
- Greenburgh, NY4 studier
- Denver, CO4 studier
- Fresno, CA4 studier
- West Jordan, UT4 studier
Efter delstat
- Alabama4 studier
- Californien6 studier
- Colorado4 studier
- District of Columbia4 studier
- Florida4 studier
- Idaho4 studier
- Illinois6 studier
- Massachusetts4 studier
- Michigan4 studier
- Minnesota5 studier
- New Jersey4 studier
- New York5 studier
- North Carolina5 studier
- Ohio5 studier
- Oklahoma4 studier
- Oregon4 studier
- Pennsylvania3 studier
- South Carolina4 studier
- Tennessee5 studier
- Texas4 studier
- Utah5 studier
- Virginia5 studier
- Washington5 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Observational, Non-interventional Biomarker and Endotyping Study
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07675265Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 23. sep. 2026 · NCT07613099Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT07449572Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06476132JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06701682Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2026 · NCT06513949Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
RekruttererObservationsstudie
Alder 21 til 90 · Alle køn · Opdateret 10. jun. 2026 · NCT07125079Recovery of Physical Function After Critical Illness In Older Adults
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 99 · Alle køn · Opdateret 28. maj 2026 · NCT07225257Clinical Decision Support Tool in PARDS Pilot Study
Rekrutterer
1 Month – 18 Years · Alle køn · Opdateret 14. apr. 2026 · NCT04068012This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT06853223Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.